Stewart D J. Lung cancer: prevention, management, and emerging therapies[M]. New York: Humana Press, 2010: 227.
[2]
Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention[J]. J Nutr Biochem, 2007, 18(7): 427.
[3]
Moon Y J, Wang X, Morris M E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism[J]. Toxicol In Vitro, 2006, 20(2): 187.
[4]
Zhang Q, Zhao X H, Wang Z J. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis[J]. Toxicol In Vitro, 2009, 23(5): 797.
[5]
Sasaki N. Protective effects of flavonoids on the cytotoxicity of linoleic acid hydroperoxide toward rat pheochromocytoma PC12 cells[J]. Chemi Biol Interact, 2003, 145(1): 101.
[6]
Brown J E. Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties[J]. Biochem J, 1998, 330 (3): 1173.
[7]
Galati G. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation[J]. Free Radic Biol Med, 2001, 30(4): 370.
[8]
Shi R X, Ong C N, Shen H M. Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells[J]. Oncogene, 2004, 23(46): 7712.
[9]
Shi R X, Ong C N, Shen H M. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells[J]. Cancer Res, 2005, 65(17): 7815.
[10]
Li X. Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines[J]. Toxicol In Vitro, 2011, 25(3): 630.
[11]
Ishikawa Y, Kitamura M. Dual potential of extracellular signal-regulated kinase for the control of cell survival[J]. Biochem Biophys Res Commun, 1999, 264(3): 696.
[12]
Ichijo H. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways[J]. Science, 1997, 275(5296): 90.
[13]
Jang S, Kelley K W, Johnson R W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1[J]. Proc Natl Acad Sci USA, 2008, 105(21): 7534.
[14]
Kimata M. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells[J]. Clin Exp Allergy, 2000, 30(4): 501.
[15]
Ando C. Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation[J]. FEBS Lett, 2009, 583(22): 3649.
[16]
Nagata S. Apoptosis by death factor[J]. Cell, 1997, 88(3): 355.
[17]
Chiang C T, Way T D, Lin J K. Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21(WAF1/CIP1) expression with rapamycin[J]. Mol Cancer Ther, 2007, 6(7): 2127.
[18]
Bagli E. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis: inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3\'-kinase activity[J]. Cancer Res, 2004, 64(21): 7936.
[19]
Hertog M G. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands[J]. Nutr Cancer, 1993, 20(1): 21.
[20]
Ashokkumar P, Sudhandiran G. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis[J]. Biomed Pharmacother, 2008, 62(9): 590.
[21]
Shi R. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization[J]. Mol Cancer Ther, 2007, 6(4): 1338.
